Pharmacological attenuation of blood pressure variability
Abstract
Over the past few years, the research team of Professor
Ding-feng SU has reported an impressive quantity of experimental
data about the relationships between blood pressure
variability (BPV) and end-organ damage, a topic of obvious
clinical interest. This research work has been summarized in
a paper that appeared in the August issue of the renowned
journal Trends in Pharmacological Sciences[1]. The studies
by Su et al provide convincing evidence that BPV is an independent
cardiovascular risk factor that should be considered
as such and, therefore, might become an important target
for therapeutic interventions. Besides these exciting perspectives
in the prevention and treatment of cardiovascular
diseases, the work by Su et al raises a series of physiological
questions.
Keywords:
Ding-feng SU has reported an impressive quantity of experimental
data about the relationships between blood pressure
variability (BPV) and end-organ damage, a topic of obvious
clinical interest. This research work has been summarized in
a paper that appeared in the August issue of the renowned
journal Trends in Pharmacological Sciences[1]. The studies
by Su et al provide convincing evidence that BPV is an independent
cardiovascular risk factor that should be considered
as such and, therefore, might become an important target
for therapeutic interventions. Besides these exciting perspectives
in the prevention and treatment of cardiovascular
diseases, the work by Su et al raises a series of physiological
questions.